Lamberto Andreotti, chief executive officer of Bristol-Myers Squibb Co., speaks during an investor meeting in New York in 2010. Photographer: Daniel Acker/Bloomberg
Lamberto Andreotti, chief executive officer of Bristol-Myers Squibb Co., speaks during an investor meeting in New York in 2010. Photographer: Daniel Acker/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=189023365&utmp=%2Fphoto%2F2012-06-30%2Fbristol-myers-to-acquire-diabetes-maker-amylin-for-5-3-billion&utmhn=10.248.67.17&utmac=UA-11413116-12&utmhid=862458688)